2Tse WP, Cheng CH, Che CT, et al. Arsenic trioxide, arsenic pentoxide, and arsenic iodide inhibit human keratinocyte proliferation through the induction of apoptosis. J Pharmacol Exp Ther, 2008, 326(2): 388-394.
3Tse WP, Cheng CH, Che CT, et al. Realgar-mediated growth inhibition on HaCaT human keratinocytes is associated with induction of apoptosis. Int J Mol Med, 2009, 24(2): 189-196.
4Liao WT, Chang KL, Yu CL, et al. Arsenic induces human keratinocyte apoptosis by the FAS/FAS ligand pathway, which correlates with alterations in nuclear factor-kappa B and activator protein-1 activity. J Invest Dermatol, 2004, 122(1 ): 125-129.
5Bi X, Gu J, Guo Z, et al. Different pathways are involved in arsenic-trioxide-induced cell proliferation and growth inhibition in human keratinocytes. Skin Pharmaeol Physiol, 2010, 23 (2): 68-78.
6Huang HS, Liu ZM, Hong DY. Blockage of JNK pathway enhances arsenic trioxide-induced apoptosis in human keratinocytes. Toxicol Appl Pharmacol, 2010, 244(2): 234-241.
7Michel L, Dupuy A, Jean-Louis F, et al. Arsenic trioxide induces apoptosis of cutaneous T cell lymphoma cells: evidence for a partially caspase-independent pathway and potentiation by ascorbic acid (vitamin C). J Invest Dermatol, 2003, 121 (4): 881-893.
8Tun-Kyi A, Qin JZ, Oberholzer PA, et al. Arsenic trioxide down-regulates antiapoptotic genes and induces cell death in mycosis fungoides tumors in a mouse model. Ann Oncol, 2008, 19 (8): 1488-1494.
9Amaria RN, Lewis KD, Gonzalez R. Therapeutic options in cutaneous melanoma: latest developments. Ther Adv Med Oncol, 2011, 3(5): 245-251.
10. Hiwatashi Y, Tadokoro H, Henmi K, et al. Antiproliferative and anti-invasive effects of inorganic and organic arsenic compounds on human and murine melanoma ceils in vitro. J Pharm Pharmacol, 2011, 63(9): 1202-1210.
